Estimating the Impact of Adding C-Reactive Protein as a Criterion for Lipid Lowering Treatment in the United States

BACKGROUND: There is growing interest in using C-reactive protein (CRP) levels to help select patients for lipid lowering therapy—although this practice is not yet supported by evidence of benefit in a randomized trial. OBJECTIVE: To estimate the number of Americans potentially affected if a CRP cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Woloshin, Steven, Schwartz, Lisa M., Kerin, Kevin, Welch, H. Gilbert
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1824732/
https://www.ncbi.nlm.nih.gov/pubmed/17356986
http://dx.doi.org/10.1007/s11606-006-0033-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1824732/
https://www.ncbi.nlm.nih.gov/pubmed/17356986
http://dx.doi.org/10.1007/s11606-006-0033-z

Ejemplares similares